Status:
UNKNOWN
Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial
Lead Sponsor:
Zagazig University
Conditions:
Psoriasis
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Psoriasis affects around 4% of world population. The disease could be disabling and disfiguring dermatologic condition. World Health Organization (WHO) has recently drawn the attention to the inadequa...
Detailed Description
Psoriasis is a prevalent skin disorder. It affects around 4% of world's population. It can be disfiguring and disabling in severe cases. There is dysregulated immune response in psoriatic patients to ...
Eligibility Criteria
Inclusion
- Patients with mild to moderate psoriasis vulgaris of any age \& gender.
- Patient didn't receive any systemic or topical therapy for psoriasis the last 4 weeks.
Exclusion
- Patients previously received topical or systemic therapy for psoriasis in the past 4 weeks.
- Patients with pustular or erythrodermic psoriasis.
- Patients with other dermatological diseases.
- Patients have hypersensitivity from the active ingredients of the therapy.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04071106
Start Date
September 1 2019
End Date
December 31 2019
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.